August 2014 Vol 7, Special Issue ASCO 2014 Payers' Perspectives in Oncology

Stakeholder Integration Needed to Address a Flawed Reimbursement System
Matthew Mitchell, PharmD, MBA, FAMCP
August 2014 Vol 7, Special Issue ASCO 2014 Payers' Perspectives in Oncology - Payers' Perspectives
Read More
ALTTO: Dual Anti-HER2 Adjuvant Therapy No Better than Trastuzumab Alone
Phoebe Starr
August 2014 Vol 7, Special Issue ASCO 2014 Payers' Perspectives in Oncology
Read More
Less May Be “More” with Zoledronic Acid
Caroline Helwick
August 2014 Vol 7, Special Issue ASCO 2014 Payers' Perspectives in Oncology
Read More
Adjuvant Exemestane More Effective than Tamoxifen in Early-Stage Breast Cancer
Wayne Kuznar
August 2014 Vol 7, Special Issue ASCO 2014 Payers' Perspectives in Oncology
Read More
Novel Drug Classes Make News in Multiple Myeloma
Caroline Helwick
August 2014 Vol 7, Special Issue ASCO 2014 Payers' Perspectives in Oncology
Read More
Federal Spending on Cancer Research and Access to Care Woefully Inadequate
Wayne Kuznar
August 2014 Vol 7, Special Issue ASCO 2014 Payers' Perspectives in Oncology
Read More
Payment Reform Key to Value-Based Cancer Care
Wayne Kuznar
August 2014 Vol 7, Special Issue ASCO 2014 Payers' Perspectives in Oncology
Read More
Ibrutinib Outperforms Ofatumumab in Patients with Relapsed/Refractory CLL
Caroline Helwick
August 2014 Vol 7, Special Issue ASCO 2014 Payers' Perspectives in Oncology
Read More
2014 Oncology Pipeline Looks Impressive
Caroline Helwick, Wayne Kuznar
August 2014 Vol 7, Special Issue ASCO 2014 Payers' Perspectives in Oncology
Read More
Patients with Cancer Are Not Asking for Costly, Excessive Treatments
Wayne Kuznar
August 2014 Vol 7, Special Issue ASCO 2014 Payers' Perspectives in Oncology
Read More
Page 1 of 4
Results 1 - 10 of 32
  • Association for Value-Based Cancer Care
  • Oncology Practice Management
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Rheumatology Practice Management
  • Urology Practice Management
  • Lynx CME